23793

0

QUESTLAB

img img img img
No Data Available

QUEST LABORATORIES LTD Share Price Update

As of the latest trading session, QUEST LABORATORIES LTD is trading at ₹116.95, up by ₹0.84 or 0.72% from its previous close. The stock has moved between ₹113.00 and ₹117.00 today. Over the past year, the stock has delivered a return of 16.09%. In the last month, it has returned -11.97%.

QUEST LABORATORIES LTD performance

Today’s low Today’s high
₹ 113.00 ₹ 117.00
₹ 116.95
52 week low 52 week high
₹ 75.15 ₹ 152.60
₹ 116.95
Open Price ₹ 113.00
Prev. Close ₹ 116.10
Volume (Shares) 21600.00
Total traded value ₹ 25.26
Upper Circuit ₹ 139.30
Lower Circuit ₹ 92.90
info

Investment Returns

Over 1 Month -11.97% Over 3 Months -3.85% Over 6 Months 33.44% Over 1 Year 16.09%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

QUEST LABORATORIES LTD fundamentals


  • Market cap (Cr) 191.60
  • P/E Ratio (TTM) 13.61
  • Beta 0.71
  • Book Value / share 54.87
  • Return on equity 24.57%
  • EPS (TTM) 8.59
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 4.03
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

QUEST LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 30.61
Operating Expense 24.38
Net Profit 4.03
Net Profit Margin (%) 13.16
Earnings Per Share (EPS) 2.46
EBITDA 7.47
Effective Tax Rate (%) 40.88
Particulars SEP 2025 (Values in Cr)
Revenue 25.62
Operating Expense 23.02
Net Profit 4.02
Net Profit Margin (%) 15.69
Earnings Per Share (EPS) 2.45
EBITDA 4.81
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 23.18
Operating Expense 20.22
Net Profit 4.10
Net Profit Margin (%) 17.68
Earnings Per Share (EPS) 2.50
EBITDA 5.67
Effective Tax Rate (%) 14.93
Particulars MAR 2025 (Values in Cr)
Revenue 46.45
Operating Expense 46.19
Net Profit 1.94
Net Profit Margin (%) 4.17
Earnings Per Share (EPS) 1.18
EBITDA 4.23
Effective Tax Rate (%) 47.13
Particulars DEC 2024 (Values in Cr)
Revenue 14.84
Operating Expense 14.36
Net Profit 0.78
Net Profit Margin (%) 5.25
Earnings Per Share (EPS) 0.47
EBITDA 0.97
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 103.91
Operating Expense 89.47
Net Profit 13.57
Net Profit Margin (%) 13.05
Earnings Per Share (EPS) 8.28
EBITDA 20.23
Effective Tax Rate (%) 27.40
Particulars MAR 2024 (Values in Cr)
Revenue 82.56
Operating Expense 68.35
Net Profit 10.09
Net Profit Margin (%) 12.22
Earnings Per Share (EPS) 9.11
EBITDA 15.79
Effective Tax Rate (%) 30.10
Particulars MAR 2023 (Values in Cr)
Revenue 61.64
Operating Expense 54.89
Net Profit 5.04
Net Profit Margin (%) 8.17
Earnings Per Share (EPS) 46.76
EBITDA 8.07
Effective Tax Rate (%) 27.79
Particulars MAR 2022 (Values in Cr)
Revenue 59.48
Operating Expense 53.77
Net Profit 4.11
Net Profit Margin (%) 6.90
Earnings Per Share (EPS) 38.05
EBITDA 6.52
Effective Tax Rate (%) 28.76
Particulars MAR 2021 (Values in Cr)
Revenue 30.36
Operating Expense 29.65
Net Profit 0.66
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 6.07
EBITDA 1.49
Effective Tax Rate (%) 16.45
Particulars MAR 2025 (Values in Cr)
Book Value / Share 49.92
ROE % 24.57
ROCE % 26.88
Total Debt to Total Equity 0.32
EBITDA Margin 19.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 24.01
ROE % 46.10
ROCE % 57.49
Total Debt to Total Equity 0.21
EBITDA Margin 19.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 139.97
ROE % 40.16
ROCE % 46.68
Total Debt to Total Equity 0.29
EBITDA Margin 13.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share 92.64
ROE % 51.73
ROCE % 54.76
Total Debt to Total Equity 0.39
EBITDA Margin 10.98
Particulars MAR 2021 (Values in Cr)
Book Value / Share 54.58
ROE % 11.21
ROCE % 12.25
Total Debt to Total Equity 0.52
EBITDA Margin 4.91
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 121.64
Total Liabilities 121.64
Total Equity 81.80
Share Outstanding 1
Price to Book Ratio 2.05
Return on Assets (%) 11.15
Return on Capital (%) 12.11
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 60.53
Total Liabilities 60.53
Total Equity 28.66
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 16.67
Return on Capital (%) 29.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 46.94
Total Liabilities 46.94
Total Equity 15.09
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 10.74
Return on Capital (%) 26.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.56
Total Assets 34.79
Total Liabilities 34.79
Total Equity 9.99
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 11.79
Return on Capital (%) 31.29
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 18.39
Total Liabilities 18.39
Total Equity 5.88
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 3.56
Return on Capital (%) 7.34
Particulars MAR 2025 (Values in Cr)
Net Income 18.68
Cash from Operations -19.24
Cash from Investing -43.96
Cash from Financing 67.42
Net change in Cash 0.13
Free Cash Flow -15.76
Particulars MAR 2024 (Values in Cr)
Net Income 14.44
Cash from Operations 7.22
Cash from Investing -5.02
Cash from Financing 2.03
Net change in Cash 0.02
Free Cash Flow 8.15
Particulars MAR 2023 (Values in Cr)
Net Income 6.98
Cash from Operations 5.67
Cash from Investing -3.82
Cash from Financing 0.00
Net change in Cash 0.05
Free Cash Flow 8.68
Particulars MAR 2022 (Values in Cr)
Net Income 5.76
Cash from Operations 3.72
Cash from Investing -1.88
Cash from Financing -0.41
Net change in Cash 1.15
Free Cash Flow 5.65
Particulars MAR 2021 (Values in Cr)
Net Income 0.78
Cash from Operations 1.45
Cash from Investing -1.19
Cash from Financing 0.03
Net change in Cash -0.11
Free Cash Flow 2.66
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 14.41 1.68 267.30 23.12 40.00
BLISS GVS PHARMA LTD. 396.35 32.07 3.51 4192.95 118.35 399.00
CIPLA LTD 1418.20 28.08 3.32 114562.27 1165.55 1672.20
FERMENTA BIOTECH LIMITED 293.20 12.93 2.12 862.92 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2301.05 38.19 17.19 38981.18 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 24.39 4.49 267.30 23.12 40.00
AMRUTANJAN HEALTH CARE LTD. 559.20 25.06 4.36 1616.68 490.00 789.95
ASTRAZENECA PHARMA IND LT 8655.30 104.02 27.08 21638.25 7630.00 10653.05
BLISS GVS PHARMA LTD. 396.35 42.62 3.62 4192.95 118.35 399.00

QUEST LABORATORIES LTD shareholding pattern

Holding
30.56%
66.78%
0.6%
2.04%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

QUEST LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
116.95 0.73 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 115.70
  • 26 Days 118.20
  • 10 Days 115.60
  • 50 Days 117.50
  • 12 Days 116.00
  • 100 Days 113.30
  • 20 Days 117.70
  • 200 Days 109.20
117.72 PIVOT
First Support 113.93 First Resistance 119.88 Second Support 111.77 Second Resistance 123.67 Third Support 107.98 Third Resistance 125.83
RSI 48.09 ADX 13.76 MACD -2.43 Williams % R -67.94 Commodity Channel Index (CCI) -29.21
Date 2026-05-27 Week 29200.00 Same Day 18000.00 Month 84273.00
1 Year 0.69 3 Year 0.45
Over 1 Month
-11.97% down
Over 1 Year
16.09% down
Over 3 Months
-3.85% down
Over 3 Years
-7.63% down
Over 6 Months
33.44% down
Over 5 Years
0.00% down

QUEST LABORATORIES LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Quest Laboratories Ltd?

Answer Field

Quest Laboratories Ltd share price is for NSE ₹ 116.95 & for BSE ₹ 0.00 as on May 29 2026 03:27 PM.

What is the Market Cap of Quest Laboratories Ltd Share?

Answer Field

The market cap of Quest Laboratories Ltd for NSE ₹ 191.60 & for BSE ₹ 0.00 as on May 29 2026 03:27 PM.

What is the 52 Week High and Low of Quest Laboratories Ltd?

Answer Field

The 52 Week High and Low of Quest Laboratories Ltd for NSE is ₹ 152.60 and ₹ 75.15 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Quest Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 39.64%.

What is the P/E Ratio of Quest Laboratories Ltd Share?

Answer Field

As on May 29 2026 03:27 PM the price-to-earnings (PE) ratio for Quest Laboratories Ltd share is 13.61.

What is the PB ratio of Quest Laboratories Ltd Share?

Answer Field

As on May 29 2026 03:27 PM, the price-to-book (PB) ratio for Quest Laboratories Ltd share is 54.87.

How to Buy Quest Laboratories Ltd Share?

Answer Field

You can trade in Quest Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Quest Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Quest Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Quest Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|